879999-15-2

Upstream product

• 4099-85-8 ((3aR,4R,6R,6aR)-6-methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methanol 
• 42060-32-2 N-benzyl-2-nitrobenzenesulfonamide 
• 879999-14-1 Acetic acid (2R,3R,4R,5S)-4,5-diacetoxy-2-{[benzyl-(2-nitro-benzenesulfonyl)-amino]-methyl}-tetrahydro-furan-3-yl ester 
• 10457-14-4 O,O'-bis-(trimethylsilyl)uracil 

Downstream Products

• 879999-16-3 N-benzyl-N-[6-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-2,2-dimethyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-ylmethyl]-2-nitro-benzenesulfonamide 
• 879999-17-4 2,3-isopropylidenedioxy-5-(N-benzylamino)-1-uracyl-β-D-ribofuranose 

Relevant academic research and scientific papers

Synthetic studies of liposidomycin degradation product: Attempt for introduction of an uracil group

Toward the synthesis of liposidomycin degradation product, the introduction of a uracil group was studied. In the presence of an N-methyl group on the diazepanone ring, the introduction of a uracil group failed. The O-nitrobenzenesulfonyl (Ns) protecting